Rigel Pharmaceuticals
RIGL
RIGL
104 hedge funds and large institutions have $153M invested in Rigel Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 15 closing their positions.
Holders
104
Holders Change
+1
Holders Change %
+0.97%
% of All Funds
3.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
32
Reduced
25
Closed
15
Calls
$6K
Puts
$5K
Net Calls
+$1K
Net Calls Change
-$76K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$5.93M |
| 2 |
SAM
2
Senzar Asset Management
New York
|
$4.03M |
| 3 |
3
Balyasny Asset Management
Chicago,
Illinois
|
$1.2M |
| 4 |
BACM
4
Blue Arrow Capital Management
New York
|
$1.26M |
| 5 |
BC
5
Broadfin Capital
New York
|
$11.6M |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$313K |
| 2 |
2
Wellington Management Group
Boston,
Massachusetts
|
$9.58M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$821K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$7.23M |
| 5 |
CCI
5
Columbus Circle Investors
|
$0 |
